UK markets closed

NIKKEI 225
38,837.46
-85.54(-0.22%)
HANG SENG
18,444.11
+41.11(+0.22%)
CRUDE OIL
72.86
-0.39(-0.53%)
GOLD FUTURES
2,347.50
+0.10(+0.00%)
DOW
38,711.29
+140.26(+0.36%)
Bitcoin GBP
55,348.57
+1,396.88(+2.59%)

The future of life time allowance

How Labour and Conservative policies will impact pension planning

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Real-time price. Currency in USD

Add to watchlist

238.50

-0.34

(-0.14%)

At close: 04:00PM EDT

238.01

-0.49

(-0.21%)

After hours:

05:14PM EDT

Trade prices are not sourced from all markets

All

Investor's Business Daily
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.
Zacks
Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now
BD's (BDX) robust product portfolio raises optimism about the stock.
PR Newswire
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Edwards Lifesciences (NYSE: EW), today announced a definitive agreement under which BD will acquire Edwards' Critical Care product group ("Critical Care"), a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD's portfolio of smart connected care solutions.